Catherine Ramsey
Stock Analyst at Baird
(4.14)
# 486
Out of 5,078 analysts
53
Total ratings
56.1%
Success rate
14.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Outperform | $39 → $41 | $39.11 | +4.83% | 9 | Nov 4, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $102.73 | +19.73% | 6 | Oct 28, 2025 | |
| ILMN Illumina | Maintains: Neutral | $84 → $105 | $127.55 | -17.68% | 6 | Jul 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $398.62 | -11.70% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $29.70 | +48.15% | 7 | May 6, 2025 | |
| NTRA Natera | Maintains: Outperform | $183 → $188 | $236.64 | -20.55% | 6 | Feb 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $580.37 | +14.58% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $148.81 | +7.52% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $101.20 | -25.89% | 1 | Aug 3, 2022 |
Castle Biosciences
Nov 4, 2025
Maintains: Outperform
Price Target: $39 → $41
Current: $39.11
Upside: +4.83%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $102.73
Upside: +19.73%
Illumina
Jul 28, 2025
Maintains: Neutral
Price Target: $84 → $105
Current: $127.55
Upside: -17.68%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $398.62
Upside: -11.70%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $29.70
Upside: +48.15%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $236.64
Upside: -20.55%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $580.37
Upside: +14.58%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $148.81
Upside: +7.52%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $101.20
Upside: -25.89%